QQQ   444.60 (-0.05%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
QQQ   444.60 (-0.05%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
QQQ   444.60 (-0.05%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
QQQ   444.60 (-0.05%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   905.92 (+0.38%)
NIO   4.62 (-1.07%)
AMD   182.99 (+1.89%)
BABA   72.32 (+1.02%)
T   17.55 (+0.00%)
F   13.21 (+1.15%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   176.00 (-2.29%)
DIS   122.34 (+1.12%)
AMC   3.75 (-13.59%)
PFE   27.84 (+0.22%)
PYPL   66.94 (+0.56%)
XOM   115.38 (+0.36%)
NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Price, News & Analysis

$29.54
+0.57 (+1.97%)
(As of 10:34 AM ET)
Today's Range
$26.01
$29.60
50-Day Range
$24.99
$29.57
52-Week Range
$23.10
$53.50
Volume
22,172 shs
Average Volume
181,985 shs
Market Capitalization
$695.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.50

OrthoPediatrics MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
43.9% Upside
$42.50 Price Target
Short Interest
Bearish
5.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.22mentions of OrthoPediatrics in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$477,375 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.34) to ($1.32) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.18 out of 5 stars

Medical Sector

173rd out of 939 stocks

Surgical & Medical Instruments Industry

19th out of 98 stocks

KIDS stock logo

About OrthoPediatrics Stock (NASDAQ:KIDS)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

KIDS Stock Price History

KIDS Stock News Headlines

the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Reviewing ResMed (NYSE:RMD) and OrthoPediatrics (NASDAQ:KIDS)
KIDS Apr 2024 40.000 put
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
OrthoPediatrics: Q4 Earnings Snapshot
Recap: OrthoPediatrics Q4 Earnings
Best Mattresses for Kids in 2024
OrthoPediatrics just downgraded at Truist, here's why
Decoding 5 Analyst Evaluations For OrthoPediatrics
See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
3/28/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:KIDS
Employees
247
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$42.50
High Stock Price Target
$52.00
Low Stock Price Target
$31.00
Potential Upside/Downside
+46.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-20,970,000.00
Pretax Margin
-14.33%

Debt

Sales & Book Value

Annual Sales
$148.73 million
Book Value
$16.14 per share

Miscellaneous

Free Float
15,872,000
Market Cap
$682.24 million
Optionable
Optionable
Beta
1.16
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives


KIDS Stock Analysis - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price target for 2024?

4 analysts have issued 12 month target prices for OrthoPediatrics' shares. Their KIDS share price targets range from $31.00 to $52.00. On average, they predict the company's share price to reach $42.50 in the next year. This suggests a possible upside of 43.9% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2024?

OrthoPediatrics' stock was trading at $32.51 at the beginning of 2024. Since then, KIDS stock has decreased by 9.1% and is now trading at $29.54.
View the best growth stocks for 2024 here
.

Are investors shorting OrthoPediatrics?

OrthoPediatrics saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 941,200 shares, an increase of 9.9% from the February 29th total of 856,800 shares. Based on an average daily volume of 176,700 shares, the short-interest ratio is presently 5.3 days. Approximately 5.9% of the shares of the stock are sold short.
View OrthoPediatrics' Short Interest
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our KIDS earnings forecast
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.28) by $0.13. The company earned $25.08 million during the quarter. OrthoPediatrics had a negative net margin of 14.10% and a negative trailing twelve-month return on equity of 5.03%.

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $197.0 million-$200.0 million, compared to the consensus revenue estimate of $182.9 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

OrthoPediatrics (KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (14.21%), Brown Advisory Inc. (6.98%), Braidwell LP (4.74%), Vanguard Group Inc. (3.74%), Vanguard Group Inc. (3.74%) and Granahan Investment Management LLC (3.29%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KIDS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners